Philip H Coelho - Net Worth and Insider Trading

Philip H Coelho Net Worth

The estimated net worth of Philip H Coelho is at least $3 Million dollars as of 2024-11-13. Philip H Coelho is the Director of Catalyst Pharmaceuticals Inc and owns about 149,553 shares of Catalyst Pharmaceuticals Inc (CPRX) stock worth over $3 Million. Philip H Coelho is the Director of Ampio Pharmaceuticals Inc and owns about 678 shares of Ampio Pharmaceuticals Inc (AMPE) stock worth over $1. Philip H Coelho is also the CEO of ThermoGenesis Holdings Inc and owns about 3 shares of ThermoGenesis Holdings Inc (THMO) stock worth over $0. Details can be seen in Philip H Coelho's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Philip H Coelho has not made any transactions after 2022-11-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Philip H Coelho

To

Philip H Coelho Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Philip H Coelho owns 3 companies in total, including Ampio Pharmaceuticals Inc (AMPE) , Catalyst Pharmaceuticals Inc (CPRX) , and ThermoGenesis Holdings Inc (THMO) .

Click here to see the complete history of Philip H Coelho’s form 4 insider trades.

Insider Ownership Summary of Philip H Coelho

Ticker Comapny Transaction Date Type of Owner
AMPE Ampio Pharmaceuticals Inc 2021-04-29 director
CPRX Catalyst Pharmaceuticals Inc 2022-11-23 director
THMO ThermoGenesis Holdings Inc 2006-05-12 director & Chief Executive Officer

Philip H Coelho Latest Holdings Summary

Philip H Coelho currently owns a total of 3 stocks. Among these stocks, Philip H Coelho owns 149,553 shares of Catalyst Pharmaceuticals Inc (CPRX) as of November 23, 2022, with a value of $3 Million and a weighting of 100%. Philip H Coelho owns 678 shares of Ampio Pharmaceuticals Inc (AMPE) as of April 29, 2021, with a value of $1 and a weighting of 0%. Philip H Coelho also owns 3 shares of ThermoGenesis Holdings Inc (THMO) as of May 12, 2006, with a value of $0 and a weighting of 0%.

Latest Holdings of Philip H Coelho

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CPRX Catalyst Pharmaceuticals Inc 2022-11-23 149,553 23.04 3,445,701
AMPE Ampio Pharmaceuticals Inc 2021-04-29 678 0.00 1
THMO ThermoGenesis Holdings Inc 2006-05-12 3 0.00 0

Holding Weightings of Philip H Coelho


Philip H Coelho Form 4 Trading Tracker

According to the SEC Form 4 filings, Philip H Coelho has made a total of 3 transactions in Catalyst Pharmaceuticals Inc (CPRX) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Catalyst Pharmaceuticals Inc is the sale of 100,000 shares on November 23, 2022, which brought Philip H Coelho around $2 Million.

According to the SEC Form 4 filings, Philip H Coelho has made a total of 2 transactions in Ampio Pharmaceuticals Inc (AMPE) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Ampio Pharmaceuticals Inc is the sale of 11 shares on April 29, 2021, which brought Philip H Coelho around $6,526.

According to the SEC Form 4 filings, Philip H Coelho has made a total of 0 transactions in ThermoGenesis Holdings Inc (THMO) over the past 5 years. The most-recent trade in ThermoGenesis Holdings Inc is the acquisition of 1 shares on May 12, 2006, which cost Philip H Coelho around $100,250.

Insider Trading History of Philip H Coelho

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Philip H Coelho Trading Performance

GuruFocus tracks the stock performance after each of Philip H Coelho's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Philip H Coelho is 102.96%. GuruFocus also compares Philip H Coelho's trading performance to market benchmark return within the same time period. The performance of stocks bought by Philip H Coelho within 3 months outperforms 11 times out of 15 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Philip H Coelho's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Philip H Coelho

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
8 out of 15 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 32.1 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 31.01 LIMIT LIMIT LIMIT LIMIT LIMIT

Philip H Coelho Ownership Network

Ownership Network List of Philip H Coelho

No Data

Ownership Network Relation of Philip H Coelho

Insider Network Chart

Philip H Coelho Owned Company Details

What does Ampio Pharmaceuticals Inc do?

Who are the key executives at Ampio Pharmaceuticals Inc?

Philip H Coelho is the director of Ampio Pharmaceuticals Inc. Other key executives at Ampio Pharmaceuticals Inc include Chief Operating Officer Holli Cherevka , CFO Dan Stokely , and Chief Financial Officer Chilcott, Iii Thomas E. .

Ampio Pharmaceuticals Inc (AMPE) Insider Trades Summary

Over the past 18 months, Philip H Coelho made no insider transaction in Ampio Pharmaceuticals Inc (AMPE). Other recent insider transactions involving Ampio Pharmaceuticals Inc (AMPE) include a net purchase of 146,858 shares made by J Kevin Buchi , and a net purchase of 76,890 shares made by Michael A Martino .

In summary, during the past 3 months, insiders sold 0 shares of Ampio Pharmaceuticals Inc (AMPE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ampio Pharmaceuticals Inc (AMPE) were sold and 11,187 shares were bought by its insiders, resulting in a net purchase of 11,187 shares.

Ampio Pharmaceuticals Inc (AMPE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Ampio Pharmaceuticals Inc Insider Transactions

No Available Data

Philip H Coelho Mailing Address

Above is the net worth, insider trading, and ownership report for Philip H Coelho. You might contact Philip H Coelho via mailing address: C/o Thermogenesis Corp, 2711 Citrus Road, Rancho Cordova Ca 95742.